Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: The National Cancer Institute experience

Pediatric Blood and Cancer

Volumn 44, Issue 5, 2005, Pages 449-454

  Nathan, Paul C ^a   Tsokos, Maria ^a   Long, Lauren ^a   Bernstein, Donna ^a   Wexler, Leonard H ^b   Mackall, Crystal L ^a   Helman, Lee J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemotherapy; Nonrhabdomyosarcoma soft tissue sarcoma; Pediatric

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ADVANCED CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; METASTASIS; NONRHABDOMYOSARCOMA SOFT TISSUE SARCOMA; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; SURVIVAL TIME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; HUMANS; INFANT; MALE; NEOPLASM METASTASIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS;

EID: 18144413900     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20262     Document Type: Article

References (19)

1. Smith MA, Gloeckler Ries LA. Childhood cancer: Incidence, survival, and mortality. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 4th edition. Philadelphia, PA: Lippincott, Williams & Wilkins; 2002. pp 1-12.
2. Spunt SL, Poquette CA, Hurt YS, et al. Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: An analysis of 121 patients treated at St Jude Children's Research Hospital. J Clin Oncol 1999;17: 3697-3705.
3. Ben Arush MW, Nahum MP, Meller I, et al. The role of chemotherapy in childhood soft tissue sarcomas other than rhabodmyosarcomas. Pediatric Hematology and Oncology 1999;16: 397-406.
4. Pratt CB, Pappo AS, Gieser P, et al. Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group Study. J Clin Oncol 1999;17:1219.
5. Pappo AS, Rao BN, Jenkins JJ, et al. Metastatic nonrhabdomyosarcomatous soft-tissue sarcomas in children and adolescents: The St. Jude Children's Research Hospital experience. Med Pediatr Oncol 1999;33:76-82.
6. Pratt CB, Maurer H, Gieser P, et al. Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: A Pediatric Oncology Group Study. Med Pediatr Oncol 1998;30:201-209.
7. Walter AW, Shearer PD, Pappo AS, et al. A pilot study of vincristine, ifosfamide, and doxorubicin in the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomas. Med Pediatr Oncol 1998;30:210-216.
8. Parham DM, Webber BL, Jenkins JJ 3rd, et al. Nonrhabdomyosarcomatous soft tissue sarcomas of childhood: Formulation of a simplified system for grading. Mod Pathol 1995;8:705-710.
9. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
11. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50:103.
12. Wexler LH, DeLaney TF, Tsokos M, et al. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors. Cancer 1996;78: 901-911.
13. Spunt SL, Hill DA, Motusue AM, et al. Clinical features and outcome of initially unresected nonmetastatic pediatic nonrhabdomyosarcoma soft tissue sarcoma. J Clin Oncol 2002;20:3225-3235.
14. Pappo AS, Devidas M, Jenkins JJ, et al. Vincristine (V), ifosfamide (I), doxorubicin (D), and G-CSF (G) for pediatiic unresected metastatic non-rhabdomyosarcomatous soft tissue sarcoma (NRSTS): A Pediatric Oncology Group (POG) study. Proceedings of the American Society of Clinical Oncology; Vol 20, Abstract 2173, 2001.
15. Pappo AS, Fontanesi J, Luo X, et al. Synovial sarcoma in children and adolescents: The St Jude Children's Research Hospital experience. J Clin Oncol 1994;12:2360-2366.
16. Daw NC, Mahmoud HH, Meyer WH, et al. Bone sarcomas of the head and neck in children: The St Jude Children's Research Hospital experience. Cancer 2000;88:2172-2180.
17. Hayes-Jordan AA, Spunt SL, Poquette CA, et al. Nonrhabdomyosarcoma soft tissue sarcomas in children: Is age at diagnosis an important variable? J Pediatr Surg 2000;35:948-953; discussion 953-954.
18. Raney RB, Asmar L, Newon WA, Jr., et al. Ewing's sarcoma of soft tissues in childhood: A report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991. J Clin Oncol 1997;15:574-582.
19. MacLeod CB, Tsokos M. Gastrointestinal autonomic nerve tumor. Ultrastruct Pathol 1991;15:49-55.